Abstract
To our knowledge, five sets of criteria for total hip replacement have been proposed [1– 5]. The National Institute of Health has suggested that total hip replacement be considered in patients with radiographic evidence of joint damage, persistent pain and disability interfering with daily activities, and should not be recommended for patients at high risk of infection or those in poor general health [5]. This provides a very general statement rather than a set of criteria; this statement is not referring at all to any radiological aspect of the disease. Hawker et al. [2] defined potential candidates for total hip replacement as patients with a summed Western Ontario MacMaster University (WOMAC) OA Index score ≥39, clinical and radiographic evidence of arthritis, and no absolute contra-indication to total hip replacement. The estimate of potential need was then adjusted for willingness. The advantage of this set of criteria is that it is data-driven. The cut-off WOMAC score of 39 represents the 25th percentile of scores for patients undergoing hip or knee arthroplasty in Ontario. With regard to the potential utilisation of total hip replacement as an outcome measure, the drawbacks of these criteria are that they do not take into account either the structural severity of the disease or variability in antecedent pharmacological and non-pharmacological therapy, and also that they are sensitive to fluctuations in disease activity over time, co-morbidity and the patient’s willingness to undergo total hip replacement. They do not indicate which patients need total hip replacement, but in which patients total hip replacement is performed in Ontario, Canada.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hadorn HC, Holmes AC. Education and debate: the New Zealand priority criteria project, part I: overview. Br Med J 1997;314:131–134
Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med 2000;342:1016–1022
Lequesne M. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779–781
Maillefert JF, Gueguen A, Nguyen M, Berdah L, Lequesne M, et al. A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol 2002;29:347–352
NIH consensus development panel on total hip replacement. JAMA 1995;273:1950–1956
Lequesne M, Taccoen A. Clinical and radiographic status of patients in the ECHODIAH study who underwent THA. Pertinence of the pain-function index for operative decision making. Presse Med 2002;31:4518–4519
Dougados M, Nguyen M, Berdah L, Mazières B, Vignon E, et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Arthritis Rheum 2001;44:2539–2547
Juin P, Dieppe P, Donovan J, Peters T, Eachus J, et al. Population requirement for primary knee replacement surgery: across-sectional study. Rheumatology 2003;42:516–521
Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, et al. Recommendations for a core set of outcome measures for future phase III trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997;24:799–802
Hochberg MC, Altman RD, Brandt KD, Moskowitz RW. Design and conduct of clinical trials in osteoarthritis. Preliminary recommendations from a task force of the osteoarthritis research society. J Rheumatol 1997;24:792–794
Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, et al. Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol 1999;26:855–861
Lequesne M. Les coxopathies destructrices. Rev Rhum Mal Osteoart 1970;37:711–719
Rosenberg ZS, Shankman S, Steiner G et al. Rapid destructive osteoarthritis: clinical, radiographic and pathologic features. Radiology 1992;182:213–216
Day RO. Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist’s perspective. ClinExp Rheumatol 2001;19(suppl 25):S3–S8
Maillefert JF, Gueguen A, Nguyen M, Berdah L, M Lequesne, et al. Relevant change in radiological progression in patients with hip osteoarthritis. Part II: Determination using an expert approach. Rheumatology 2002;41:148–152
Arlet J, Jacqueline F, Depeyre M, Mazieres B, Gayrard M. La hanche dans l’hyperostose vertébrale. Rev Rhum Mal Osteoart 1978;45:17–26
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 EFORT
About this chapter
Cite this chapter
Dougados, M. (2009). Radiographic Assessment of Indications to Total Hip Replacement. In: Puhl, W., Günther, KP., Dieppe, P., Dreinhöfer, K.E. (eds) EUROHIP. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74137-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-74137-4_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74133-6
Online ISBN: 978-3-540-74137-4
eBook Packages: MedicineMedicine (R0)